Clinics (Sep 2021)

Exercise training reduces sympathetic nerve activity and improves executive performance in individuals with obstructive sleep apnea

  • Thiago Tanaka Goya,
  • Rosyvaldo Ferreira-Silva,
  • Elisangela Macedo Gara,
  • Renan Segalla Guerra,
  • Eline Rozária Ferreira Barbosa,
  • Edgar Toschi-Dias,
  • Paulo Jannuzzi Cunha,
  • Carlos Eduardo Negrão,
  • Geraldo Lorenzi-Filho,
  • Linda Massako Ueno-Pardi

DOI
https://doi.org/10.6061/clinics/2021/e2786
Journal volume & issue
Vol. 76

Abstract

Read online

OBJECTIVE: To investigate the effects of exercise training (ET) on muscle sympathetic nerve activity (MSNA) and executive performance during Stroop Color Word Test (SCWT) also referred to as mental stress test. METHODS: Forty-four individuals with obstructive sleep apnea (OSA) and no significant co-morbidities were randomized into 2 groups; 15 individuals completed the control period, and 18 individuals completed the ET. Mini-mental state of examination and intelligence quotient were also assessed. MSNA assessed by microneurography, heart rate by electrocardiography, blood pressure (automated oscillometric device) were measured at baseline and during 3 min of the SCWT. Peak oxygen uptake (VO2 peak) was evaluated using cardiopulmonary exercise testing. Executive performance was assessed by the total correct responses during 3 min of the SCWT. ET consisted of 3 weekly sessions of aerobic exercise, resistance exercises, and flexibility (72 sessions, achieved in 40±3.9 weeks). RESULTS: Baseline parameters were similar between groups. Heart rate, blood pressure, and MSNA responses during SCWT were similar between groups (p>0.05). The comparisons between groups showed that the changes in VO2 (4.7±0.8 vs -1.2±0.4) and apnea-hypopnea index (-7.4±3.1 vs 5.5±3.3) in the exercise-trained group were significantly greater than those observed in the control group respectively (p0.05). CONCLUSIONS: ET improves sympathetic response and executive performance during SCWT, suggesting a prominent positive impact of ET on prefrontal functioning in individuals with OSA. ClinicalTrials.gov: NCT002289625.

Keywords